Literature DB >> 24619537

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.

Kenichi Nishioji1, Yoshio Sumida, Mai Kamaguchi, Naomi Mochizuki, Masao Kobayashi, Takeshi Nishimura, Kanji Yamaguchi, Yoshito Itoh.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) in non-obese subjects is not rare in Japan, but it has not been clearly described. To clarify its prevalence and risk factors, we investigated the clinical characteristics of NAFLD in non-obese subjects in comparison with NAFLD in obese subjects in the Japanese general population.
METHODS: A cross-sectional study was performed with 5433 subjects who received health checkups from 2011 to 2012. Subjects consuming more than 20 g of alcohol per day and those with autoimmune liver disease, viral hepatitis, uncontrolled biliary disease and insufficient data were excluded. Subjects with a body mass index (BMI) ≥25 kg/m(2) were considered obese, and subjects with a BMI <25 kg/m(2) were considered non-obese.
RESULTS: A total of 3271 subjects were enrolled. The overall prevalence of NAFLD was 24.6%: 68.5% in obese subjects and 15.2% in non-obese subjects. The multivariate logistic regression analysis revealed that ≥10 kg of weight gain since the age of 20 was significantly associated with NAFLD in non-obese subjects of both genders, and eating an evening meal within 2 h before going to bed 3 days or more per week and drinking <20 g of alcohol per day were negatively associated in non-obese females. Metabolic factors such as waist circumference and triglycerides were predictors of NAFLD in non-obese subjects, and body fat percentage was a predictor in non-obese males.
CONCLUSIONS: Lifestyle as well as metabolic factors may play crucial roles in the pathogenesis of NAFLD, even in the non-obese Japanese population.

Entities:  

Mesh:

Year:  2014        PMID: 24619537     DOI: 10.1007/s00535-014-0948-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

Review 1.  The role of diet and nutrient composition in nonalcoholic Fatty liver disease.

Authors:  Erin Marie McCarthy; Mary E Rinella
Journal:  J Acad Nutr Diet       Date:  2012-03-01       Impact factor: 4.910

2.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

3.  Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population.

Authors:  Tomomi Saida; Wakaba Fukushima; Satoko Ohfuji; Kyoko Kondo; Ichiro Matsunaga; Yoshio Hirota
Journal:  J Gastroenterol Hepatol       Date:  2014-01       Impact factor: 4.029

4.  Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

Authors:  Chengfu Xu; Chaohui Yu; Han Ma; Lei Xu; Min Miao; Youming Li
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

5.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.

Authors:  Kausik Das; Kshaunish Das; Partha S Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

Review 6.  Exercise and the liver: implications for therapy in fatty liver disorders.

Authors:  Nathan A Johnson; Shelley E Keating; Jacob George
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

7.  Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.

Authors:  Young-Min Kwon; Seung-Won Oh; Seung-sik Hwang; CheolMin Lee; Hyuktae Kwon; Goh Eun Chung
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

8.  Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men.

Authors:  Yasushi Imamura; Hirofumi Uto; Makoto Oketani; Yasunari Hiramine; Kaori Hosoyamada; Yukihiko Sho; Takuya Hiwaki; Yoshirou Baba; Kenji Tahara; Osamu Kubozono; Ken Kusano; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2008-06-17       Impact factor: 4.288

9.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Authors:  Kevin M Korenblat; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

10.  The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.

Authors:  Ki Chul Sung; Marno C Ryan; Andrew M Wilson
Journal:  Atherosclerosis       Date:  2008-07-31       Impact factor: 5.162

View more
  40 in total

1.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.

Authors:  Zhen-Ya Lu; Zhou Shao; Ya-Li Li; Muhuyati Wulasihan; Xin-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 2.  Undiagnosed liver diseases.

Authors:  Emily Gao; Julian Hercun; Theo Heller; Sílvia Vilarinho
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 3.  Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.

Authors:  Becky Ching-Yeung Yu; Deborah Kwok; Vincent Wai-Sun Wong
Journal:  J Clin Exp Hepatol       Date:  2019-02-07

4.  Biphasic effect of alcohol intake on the development of fatty liver disease.

Authors:  Hirokazu Takahashi; Masafumi Ono; Hideyuki Hyogo; Chika Tsuji; Yoichiro Kitajima; Naofumi Ono; Takahisa Eguchi; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara; Keizo Anzai; Yuichiro Eguchi
Journal:  J Gastroenterol       Date:  2015-03-03       Impact factor: 7.527

Review 5.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

7.  Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?

Authors:  Takumi Kawaguchi; Takuji Torimura
Journal:  J Gastroenterol       Date:  2019-11-28       Impact factor: 7.527

8.  Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis.

Authors:  Qianyi Wang; Hong You; Xiaojuan Ou; Xinyan Zhao; Yameng Sun; Min Wang; Ping Wang; Yu Wang; Weijia Duan; Xiaoming Wang; Shanshan Wu; Yuanyuan Kong; Romil Saxena; Annette S H Gouw; Jidong Jia
Journal:  Hepatol Int       Date:  2019-09-26       Impact factor: 6.047

9.  Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.

Authors:  Govardhan Bale; Ravikanth V Vishnubhotla; Sasikala Mitnala; Mithun Sharma; Rao N Padaki; Smita C Pawar; Reddy N Duvvur
Journal:  J Clin Exp Hepatol       Date:  2019-02-11

Review 10.  Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.

Authors:  Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian R Davidson; Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis
Journal:  Cochrane Database Syst Rev       Date:  2017-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.